COMPANY

Pharmanest

Keywords: digital pathology Metabolic Dysfunction-associated Steatotic Liver Disease Crohn Disease Fibrostenotic Crohn's Disease CD - Crohn's Disease

Location: Princeton, NJ · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

Nov 1, 2026 Trial start —: Artificial Intelligence For Outcomes Research in Crohn's Disease: Digital Pathology Assessment of Fibrosis and Association With Patient History and Clinical Outcomes source ↗
Sep 1, 2025 Trial start —: Digital Pathology and AI for Liver Outcomes in MASLD source ↗
Sep 1, 2025 Trial start —: Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2) source ↗

Mar 15, 2027 (ESTIMATED) · · Artificial Intelligence For Outcomes Research in Crohn's Disease: Digital Pathology Assessment of Fibrosis and Association With Patient History and Clinical Outcomes · NCT07795476

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07795476	Artificial Intelligence For Outcomes Research in Crohn's Disease: Digital Pathology Assessment of Fibrosis and Association With Patient History and Clinical Outcomes	Not listed	Not yet recruiting	Nov 1, 2026	Mar 15, 2027 (estimated)
NCT06344364	Digital Pathology and AI for Liver Outcomes in MASLD	Not listed	Completed	Sep 1, 2025	Jun 1, 2026 (actual)
NCT06493253	Digital Pathology and AI for Liver Outcomes in MASLD (DPAILO-2)	Not listed	Completed	Sep 1, 2025	Mar 15, 2026 (actual)